Published in

Elsevier, Clinical Oncology, 2(13), p. 71-81

DOI: 10.1053/clon.2001.9221

Elsevier, Clinical Oncology, 2(13), p. 71-81

DOI: 10.1007/s001740170083

Links

Tools

Export citation

Search in Google Scholar

The Role of Biologically Effective Dose (BED) in Clinical Oncology

Journal article published in 2001 by B. Jones, R. G. Dale, C. Deehan, K. I. Hopkins, D. A. L. Morgan ORCID
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

There are many clinical situations in which radiobiological considerations can be usefully applied and all clinicians should be aware of the potential benefits of developing a quantitative radiobiological approach to their practice. The concept of biologically effective dose (BED) in particular is useful for quantifying treatment expectations, but clinical oncologists should recognize that careful interpretation of modelling results is required before clinical decisions can be made and that there is a lack of reliable human parameters for application in some situations. Correct use of the BED concept will, in more complex treatment situations, sometimes involve the use of multiple parameters and BED calculations. Examples include: